Bradley Foster & Sargent’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$628K Sell
1,406
-36
-2% -$16.8K 0.01% 359
2025
Q4
$654K Sell
1,442
-301
-17% -$130K 0.01% 348
2025
Q3
$683K Sell
1,743
-228
-12% -$95.3K 0.01% 343
2025
Q2
$877K Sell
1,971
-121
-6% -$55.8K 0.01% 309
2025
Q1
$1.01M Buy
2,092
+304
+17% +$142K 0.02% 270
2024
Q4
$720K Sell
1,788
-8
-0.4% -$3.71K 0.01% 312
2024
Q3
$835K Sell
1,796
-100
-5% -$48K 0.01% 307
2024
Q2
$889K Buy
1,896
+40
+2% +$17.4K 0.02% 280
2024
Q1
$776K Sell
1,856
-884
-32% -$374K 0.01% 303
2023
Q4
$1.11M Buy
2,740
+55
+2% +$20.3K 0.02% 258
2023
Q3
$945K Hold
2,685
0.02% 268
2023
Q2
$945K Buy
2,685
+13
+0.5% +$4.38K 0.02% 268
2023
Q1
$842K Hold
2,672
0.02% 265
2022
Q4
$772K Sell
2,672
-10
-0.4% -$3.05K 0.02% 275
2022
Q3
$777K Buy
2,682
+124
+5% +$35.7K 0.02% 259
2022
Q2
$721K Buy
2,558
+772
+43% +$207K 0.02% 275
2022
Q1
$466K Buy
1,786
+62
+4% +$14.7K 0.01% 354
2021
Q4
$379K Sell
1,724
-410
-19% -$79.7K 0.01% 360
2021
Q3
$387K Sell
2,134
-98,754
-98% -$19.3M 0.01% 332
2021
Q2
$20.3M Buy
100,888
+763
+0.8% +$160K 0.48% 64
2021
Q1
$21.5M Buy
100,125
+96,333
+2,540% +$21.2M 0.54% 55
2020
Q4
$896K Buy
3,792
+372
+11% +$85.4K 0.02% 227
2020
Q3
$931K Buy
+3,420
New +$944K 0.03% 206
2020
Q1
$814K Hold
3,420
0.03% 199
2019
Q4
$749K Buy
3,420
+629
+23% +$127K 0.02% 240
2019
Q3
$473K Buy
2,791
+899
+48% +$159K 0.02% 259
2019
Q2
$347K Sell
1,892
-625
-25% -$109K 0.01% 290
2019
Q1
$463K Buy
2,517
+17
+0.7% +$3.14K 0.02% 270
2018
Q4
$414K Buy
2,500
+837
+50% +$145K 0.02% 269
2018
Q3
$321K Hold
1,663
0.01% 315
2018
Q2
$283K Buy
1,663
+213
+15% +$33K 0.01% 324
2018
Q1
$236K Buy
+1,450
New +$237K 0.01% 331

Other funds holding VRTX